NEW YORK (GenomeWeb News) – Roswell Park Cancer Institute is investing $18.5 million to fund the launch of a new Center for Personalized Medicine (CPM) at its campus in Buffalo, according to the office of NY Governor Andrew Cuomo.
New York State plans to invest $49.7 million in a wide range biotechnology-focused economic development projects with funding going to research institutes, incubators, and businesses throughout the state.
Exiqon said today that it has signed a "center of excellence" agreement with the Roswell Park Cancer Institute.
Under the agreement, Buffalo, NY-based RPCI will provide real-time PCR services using Exiqon's Mircury LNA Universal RT microRNA PCR products.
The collaboration brings together Ariadne, Cellecta, and the Roswell Park Cancer Institute to develop "a better understanding of the mechanisms of prostate cancer that result in novel targets and biomarkers."